Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review-Reference-Cited by-同舟云学术

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

Published:2013 Issue:5 Volume:4 Page:78
ISSN:0976-500X
Container-title:Journal of Pharmacology and Pharmacotherapeutics
language:en
Short-container-title:J Pharmacol Pharmacother

Author:

Leporini Christian,Saullo Francesca,Filippelli Gianfranco,Sorrentino Antonio,Lucia Maria,Perri Gino,Gattuta GaetanaLa,Infusino Stefania,Toscano Rosa,Dima Gianluca,Olivito Virginia,Paletta Laura,Bottoni Ugo,De Sarro Giovambattista

Publisher

Medknow

Subject

Pharmacology (medical),Pharmacology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab;Leukemia & Lymphoma;2023-06-12

2. A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood–Brain Barrier;Biomedicines;2022-08-16

3. The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions;Journal of Clinical Medicine;2021-01-26

4. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial;International Journal of Radiation Oncology*Biology*Physics;2020-01

5. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial;Supportive Care in Cancer;2019-04-29